scholarly journals B-PO03-147 OMEGA-3 POLYUNSATURATED FATTY ACIDS REDUCES POST-OPERATIVE ATRIAL FIBRILLATION IN PATIENTS UNDERGOING CARDIAC SURGERY

Heart Rhythm ◽  
2021 ◽  
Vol 18 (8) ◽  
pp. S248-S249
Author(s):  
Siddharth Shah ◽  
Kuldeep Bharat Shah ◽  
Mohit K. Turagam ◽  
Rahul Bhardwaj ◽  
Tahmeed Contractor ◽  
...  
2015 ◽  
Vol 18 (3) ◽  
pp. 12
Author(s):  
S. M. Yefremov ◽  
Ye. A. Pokushalov ◽  
A. B. Romanov ◽  
A. M. Chernyavskiy ◽  
A. N. Shilova ◽  
...  

The study was aimed at testing the hypothesis that perioperative infusion of omega-3 polyunsaturated fatty acids would reduce the incidence of postoperative atrial fibrillation in CAD patients operated under CPB. The authors carried out a prospective, randomised, double-blind, placebo-controlled study. 39 CAD patients who had undergone surgery under cardiopulmonary bypass were randomized into 2 groups. 18 patients were infused with omega-3 polyunsaturated fatty acids (Omegaven, Fresenius Kabi, Germany) starting with 200 mg/kg/day before anaesthesia induction for 24 hours followed by 100 mg/kg/day from second to seventh day postoperatively. 21 patients received an equivalent dose of placebo (Intralipid, Fresenius Kabi, Germany). The primary endpoint was freedom from atrial fibrillation at 2-year follow-up. A Reveal cardiac monitor was implanted subcutaneously in all patients. Data from cardiac monitor was collected on the 10th day and at 3, 6, 12 and 24 months postoperatively. Postoperative atrial fibrillation developed in 4 (19%) patients in the control group and in 5 (27.8%) patients in the study group at 10-day follow-up (p = 0.88). At 2-year follow-up, 5 (27.8%) patients in the control group and 6 (35.3%) patients in the study group had atrial fibrillation (p = 0.9). The results of our research do not confirm the efficiency of perioperative infusion of omega-3 polyun-saturated fatty acids to prevent the occurrence of atrial fibrillation.


2014 ◽  
Vol 18 (2 (70)) ◽  
Author(s):  
M. A. Orynchak ◽  
M. M. Vasylechko

The condition of coagulation and platelet hemostasis in 125 patients with atrial fibrillation (AF) and with metabolic syndrome (MS) has been analysed. Сoagulation and platelet hemostasis in 125 patients with AF and MS under treatment with acetylsalicylic acid (ASA) (group 1), omega-3 polyunsaturated fatty acids (omega-3 PUFAs) (group 2) and ASA with L-arginine (3 group) during 2 months were measured. It was established that omega-3 PUFAs are more effective compared with ASA/aspirin with L-arginine and it promotes normalization of fibrinogen, soluble fibrin-monomer complexes (SFMK), D-dimer and improves the platelet aggregative activity (PAA).


Circulation ◽  
2007 ◽  
Vol 116 (19) ◽  
pp. 2101-2109 ◽  
Author(s):  
Masao Sakabe ◽  
Akiko Shiroshita-Takeshita ◽  
Ange Maguy ◽  
Chloe Dumesnil ◽  
Anil Nigam ◽  
...  

2017 ◽  
Vol 95 (8) ◽  
pp. 693-699
Author(s):  
Olesya A. Rubanenko ◽  
O. V. Fatenkov ◽  
S. M. Khokhlunov ◽  
A. P. Semagin ◽  
D. V. Kuznetsov ◽  
...  

Aim. To estimate the influence of short-term omega-3 polyunsaturated fatty acids (PUFA) treatment on the development of new cases of atrial fibrillation (AF) in patients with coronary artery disease after coronary artery bypass grafting (CABG) with the detection of indicators of inflammation, oxidative stress, myocardial injury or dysfunction. Material and methods. The patients did not receive statins at the stage of out-patient treatment. Interleukin (IL)-6, IL-8, IL-10, C-reactive protein (CRP), fibrinogen, troponin, NT-proBNP, superoxide dismutase (SOD), myeloperoxidase (MPO) levels were measured on admission and 3.6±1.3 days after CABG. All the patients were divided into two groups: group 1 comprised patients who did not receive omega-3 PUFA (51 patients, 86.3% males, mean age 62.8+4.0), 2 group included patients who received PUFA (51 patients, 90.2% males, mean age 62.1±4.0 years) 5 days (mean) before CABG at an average dose 2 g per day and for 3 weeks after CABG at an average dose 1 g per day. Results. Postoperative AF more often occurred in group 1 (41.2% vs 23.5%; p=0.04 ( mean 4.8±3.0 days). The patients of group 1 more often had FC-III angina pectoris (60.8% vs 51.0%, p=0.04), whereas patients of group 2 more often had the history of myocardial infarction (78.4% vs 58.8%, p=0.03) and respiratory pathology (23.5% vs 2.0%, p=0.0009). According to univariate regression analysis, omega-3 PUFA intake was associated with a decrease of new episodes of AF at the early postoperative period (odds ratio (OR) 0.66; 95% confidence interval (CI) 0.43-0.9; p=0.04). IL-6 levels were significantly higher in pre- and postoperative periods in patients of group 1 (34.8±25.5 pg/ml vs 2.9±2.5 pg/ml, p<0.0001; 54.6±44.9 pg/ml vs 39.5±29.7 pg/ml, p=0.04, respectively). Before CABG, SOD levels in both groups were higher than normal (group 1 - 3478.6±2365.7 units/g vs group 2 - 2893.4±2365.7 units/g, p>0.05). After CABG, SOD levels became lower in both groups but remained significantly higher in group 1 (2311.8±1371.6 units/g vs 662.5±572.4 units/g, р<0.0001). MPO after CABG was insignificantly raised in group 1 (before CABG - 176.8±83.8 mg/l, after CABG - 212.5±131.8 mg/l) and lowered in patients with omega-3 PUFA intake (280.4±202.1 before and 235.3±147.6 after CABG). Conclusions. The study showed that omega-3 PUFA intake in perioperative period of CABG leads to a significant decrease in occurrence of new AF cases. The patients who received omega-3 had lower IL-6 levels as a proinflammatory factor and SOD level as a marker of oxidative stress.


2007 ◽  
Vol 77 (s1) ◽  
pp. A10-A10 ◽  
Author(s):  
C. M. W. Cole ◽  
K. M. Kostner ◽  
J. Mundy ◽  
T. Marwick ◽  
P. Peters

Sign in / Sign up

Export Citation Format

Share Document